The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection
Open accessAbstract
Secondary pneumococcal pneumonia is a serious complication during and shortly after influenza infection. We established a mouse model to study postinfluenza pneumococcal pneumonia and evaluated the role of IL-10 in host defense against Streptococcus pneumoniae after recovery from influenza infection. C57BL/6 mice were intranasally inoculated with 10 median tissue culture infective doses of influenza A (A/PR/8/34) or PBS (control) on day 0. By day 14 mice had regained their normal body weight and had cleared influenza virus from the lungs, as determined by real-time quantitative PCR. On day 14 after viral infection, mice received 104 CFU of S. pneumoniae (serotype 3) intranasally. Mice recovered from influenza infection were highly susceptible to subsequent pneumococcal pneumonia, as reflected by a 100% lethality on day 3 after bacterial infection, whereas control mice showed 17% lethality on day 3 and 83% lethality on day 6 after pneumococcal infection. Furthermore, 1000-fold higher bacterial counts at 48 h after infection with S. pneumoniae and, particularly, 50-fold higher pulmonary levels of IL-10 were observed in influenza-recovered mice than in control mice. Treatment with an anti-IL-10 mAb 1 h before bacterial inoculation resulted in reduced bacterial outgrowth and markedly reduced lethality during secondary bacterial pneumonia compared with those in IgG1 control mice. In conclusion, mild self-limiting influenza A infection renders normal immunocompetent mice highly susceptible to pneumococcal pneumonia. This increased susceptibility to secondary bacterial pneumonia is at least in part caused by excessive IL-10 production and reduced neutrophil function in the lungs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“Primary influenza virus infection leads to recruitment of lymphocytes and macrophages, which are both able to release IL-10 (32).”
BackgroundYearbook of Intensive Care and Emergency Medicine 2002
(2002) · Springer eBooks · doi:10.1007/978-3-642-56011-8 · Cited by 876
The impact of influenza epidemics on mortality: introducing a severity index.
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.12.1944 · Cited by 587
STUDIES ON INFLUENZA IN THE PANDEMIC OF 1957-1958. II. PULMONARY COMPLICATIONS OF INFLUENZA*†
Louria, D. B., Blumenfeld, H. L., Ellis, J. T., Kilbourne, E. D., & Rogers, D. E. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103791 · Cited by 479
Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR
van Elden, L. J. R., Nijhuis, M., Schipper, P., Schuurman, R., & van Loon, A. M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.196-200.2001 · Cited by 456
Self-citationMcCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423 · cited 2×
“pneumoniae confirms earlier reports of bacterial complications following influenza infection (9, 11).”
BackgroundNeutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia
Greenberger, M. J., Strieter, R. M., Kunkel, S. L., Danforth, J. M., Goodman, R. E., & Standiford, T. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.722 · Cited by 325
Alveolar Macrophages Have a Protective Antiinflammatory Role during Murine Pneumococcal Pneumonia
Knapp, S., Leemans, J. C., Florquin, S., Branger, J., Maris, N. A., Pater, J., van Rooijen, N., & van der Poll, T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-698oc · Cited by 302
Self-citation
Cited by
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 747
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
van der Poll, T., & Opal, S. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61114-4 · Cited by 720
Self-citationViral and Bacterial Interactions in the Upper Respiratory Tract
Bosch, A. A. T. M., Biesbroek, G., Trzcinski, K., Sanders, E. A. M., & Bogaert, D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003057 · Cited by 651
Sun, K., & Metzger, D. W. (2008) · Nature Medicine · doi:10.1038/nm1765 · Cited by 587
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections
Ghoneim, H. E., Thomas, P. G., & McCullers, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300014 · Cited by 394
Regulating the adaptive immune response to respiratory virus infection
Braciale, T. J., Sun, J., & Kim, T. S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3166 · Cited by 361
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 340
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
Rynda-Apple, A., Robinson, K. M., & Alcorn, J. F. (2015) · Infection and Immunity · doi:10.1128/iai.00298-15 · Cited by 286
Brown, D. M., Dilzer, A. M., Meents, D. L., & Swain, S. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2888 · Cited by 282
Nakamura, S., Davis, K. M., & Weiser, J. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57762 · Cited by 280
The two faces of interleukin 10 in human infectious diseases
Mege, J.-L., Meghari, S., Honstettre, A., Capo, C., & Raoult, D. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70577-1 · Cited by 257
Wang, J., Li, F., Sun, R., Gao, X., Wei, H., Li, L.-J., & Tian, Z. (2013) · Nature Communications · doi:10.1038/ncomms3106 · Cited by 239
McNamee, L. A., & Harmsen, A. G. (2006) · Infection and Immunity · doi:10.1128/iai.00789-06 · Cited by 233
Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell
Shi, Y., Yamazaki, T., Okubo, Y., Uehara, Y., Sugane, K., & Agematsu, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3262 · Cited by 229
“Recently, it was reported that increased susceptibility to secondary pneumococcal pneumonia is at least in part caused by excessive IL-10 production and reduced neutrophil function in the lung (26).”
BackgroundSmall, C.-L., Shaler, C. R., McCormick, S., Jeyanathan, M., Damjanovic, D., Brown, E. G., Arck, P., Jordana, M., Kaushic, C., Ashkar, A. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902772 · Cited by 216
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23776.x · Cited by 193
Influenza A virus facilitates Streptococcus pneumoniae transmission and disease
Diavatopoulos, D. A., Short, K. R., Price, J. T., Wilksch, J. J., Brown, L. E., Briles, D. E., Strugnell, R. A., & Wijburg, O. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-146779 · Cited by 192
“Specifically, influenza virus may reduce the activity of neutrophils (42), alter the cytokine environment (43), or reduce Toll-like receptor signaling (44), all of which would have important consequences for the immune response in the nasopharynx.”
BackgroundJamieson, A. M., Yu, S., Annicelli, C. H., & Medzhitov, R. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.010 · Cited by 180
Influenza virus primes mice for pneumonia from Staphylococcus aureus.
Iverson, A. R., Boyd, K. L., McAuley, J. L., Plano, L. R., Hart, M. E., & McCullers, J. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq113 · Cited by 168
Gleeson, M., Bishop, N., Oliveira, M., McCauley, T., Tauler, P., & Muhamad, A. S. (2012) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2010.01272.x · Cited by 165
Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes
Warszawska, J. M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67911 · Cited by 148
Ademokun, A., Wu, Y., Martin, V., Mitra, R., Sack, U., Baxendale, H., Kipling, D., & Dunn‐Walters, D. K. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00732.x · Cited by 139
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138
The immunology of influenza virus-associated bacterial pneumonia.
Robinson, K. M., Kolls, J. K., & Alcorn, J. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.002 · Cited by 132
Robinson, K. M., McHugh, K. J., Mandalapu, S., Clay, M. E., Lee, B., Scheller, E. V., Enelow, R. I., Chan, Y. R., Kolls, J. K., & Alcorn, J. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit527 · Cited by 131
van der Sluijs, K. F., Nijhuis, M., Levels, J. H. M., Florquin, S., Mellor, A. L., Jansen, H. M., der Poll, T. V., & Lutter, R. (2006) · The Journal of Infectious Diseases · doi:10.1086/498911 · Cited by 111
Self-citationPostinfluenza bacterial pneumonia: Host defenses gone awry
Ballinger, M. N., & Standiford, T. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0049 · Cited by 103
Mina, M. J., McCullers, J. A., & Klugman, K. P. (2014) · mBio · doi:10.1128/mbio.01040-13 · Cited by 91
Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Tessmer, A., Welte, T., Schmidt-Ott, R., Eberle, S., Barten, G., Suttorp, N., & Schaberg, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00133510 · Cited by 65
Sharma-Chawla, N., Sender, V., Kershaw, O., Gruber, A. D., Volckmar, J., Henriques-Normark, B., Stegemann-Koniszewski, S., & Bruder, D. (2016) · Infection and Immunity · doi:10.1128/iai.00422-16 · Cited by 63
Disease Severity in Patients with Simultaneous Influenza and Bacterial Pneumonia
Seki, M., Kosai, K., Yanagihara, K., Higashiyama, Y., Kurihara, S., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tashiro, T., & Kohno, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6364 · Cited by 57
URI in Athletes: Are Mucosal Immunity and Cytokine Responses Key Risk Factors?
Gleeson, M., & Bishop, N. C. (2013) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3182956ead · Cited by 39
Metadata
- Authors
- van der Sluijs, K. F., van Elden, L. J. R., Nijhuis, M., Schuurman, R., Pater, J. M., Florquin, S., Goldman, M., Jansen, H. M., Lutter, R., & van der Poll, T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06
- Volume
- 172
- Issue
- 12
- Pages
- 7603-7609
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2116498531
- Cited by
- 334
- References
- 37
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.